On a per-share basis, the
The results missed
The medical device developer posted revenue of
Cardiovascular Systems expects full-year revenue in the range of
Cardiovascular Systems shares have dropped almost 8% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a
Automated Insights, source